Bio-Reference Laboratories (BRLI) Tops Q1 Views
Bio-Reference Laboratories (NASDAQ: BRLI) reported Q1 EPS of $0.28, $0.11 better than the analyst estimate of $0.17. Revenue for the quarter came in at $121.66 million versus the consensus estimate of $119.12 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stoneridge (SRI) Reports In-Line Q3 EPS, Loweres Sales Guiance
- Deluxe Corp. (DLX) Tops Q3 EPS by 1c; Updates FY16 Outlook
- CoreSite Realty (COR) Misses Q3 FFO by 1c; Boosts FY16 FFO Outlook
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!